AlphaMark Advisors »

Catalyst Pharmaceutical Partners shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $328k 17k 19.90
2019-06-30 $8.0k 2.2k 3.62

More positions owned by AlphaMark Advisors

iShares S&P 500 Etf (IVV)
Technology SPDR Etf (XLK)
Health Care SPDR (XLV)
SPDR Trust Unit SR Etf (SPY)
Procter & Gamble Company (PG)
Db-x Msci Eafe Currency-hedged (DBEF)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Financial Select Sector SPDR (XLF)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Industrial SPDR (XLI)
Select Sector Spdr Tr Communic etfeqty (XLC)
Janus Detroit Str Tr (JAAA)
Energy Select Sector SPDR (XLE)
Consumer Staples Select Sect. SPDR (XLP)
Regan Floating Rate Mbs (MBSF)

View all positions for AlphaMark Advisors

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Dimensional Fund Advisors
Pacer Advisors
Goldman Sachs Group
Renaissance Technologies
Geode Capital Management
First Trust Advisors
Morgan Stanley
Royce & Associates
Bank of America Corporation
Northern Trust
Nuveen Asset Management

View all funds holding Catalyst Pharmaceutical Partners